Drug profile · INN
calcitonin salmon
MIACALCIC 100
calcitonin salmon (MIACALCIC 100) is a calcitonin receptor agonist. Associated with Chiesi Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — calcitonin salmon
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
calcitonin salmon (MIACALCIC 100) is a calcitonin receptor agonist. Associated with Chiesi Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Calcitonin receptor agonist
Primary target: Calcitonin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is calcitonin salmon?
calcitonin salmon (MIACALCIC 100) is a calcitonin receptor agonist. Associated with Chiesi Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for calcitonin salmon?
MIACALCIC 100 is a marketed brand name for calcitonin salmon. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcitonin salmon?
calcitonin salmon has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.